Earnings Calls News and Headlines
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Earnings Calls Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Earnings CallsNewsCarlsmed Inc (CARL) Q4 2025 Earnings Call Transcript
Carlsmed Inc (CARL) Q4 2025 Earnings Call Transcript
Earnings CallsLarge Cap Stocks

Carlsmed Inc (CARL) Q4 2025 Earnings Call Transcript

•February 25, 2026
0
Motley Fool – Earnings Transcripts
Motley Fool – Earnings Transcripts•Feb 25, 2026

Why It Matters

Strong cash generation and disciplined capital returns underscore Carlisle’s resilience in a soft construction market, while its strategic focus on innovation and acquisitions positions it for long‑term margin expansion.

Key Takeaways

  • •Revenue flat; Q4 up 0.4%, full year $5B.
  • •Adjusted EPS fell 13% to $3.90 Q4.
  • •Operating cash flow >$1B; free cash flow 19.4% margin.
  • •Share repurchases $1.3B; dividend up 10% for 49th year.
  • •Vision 2030 targets reaffirmed; margin expansion expected 2026.

Pulse Analysis

Carlisle’s Q4 results highlight the durability of its core building‑envelope franchise, especially the reroofing business that now accounts for roughly 70% of CCM revenue. Even as new‑construction demand softens, the aging U.S. non‑residential building stock fuels steady reroofing permits, delivering low‑single‑digit top‑line growth and supporting cash flow generation. The company’s ability to sustain over $1 billion of operating cash flow for four consecutive years reflects a robust operating system and disciplined cost management, allowing it to return $1.5 billion to shareholders through buybacks and dividend hikes while preserving a strong balance sheet.

Margin pressure in both CCM and CWT segments stemmed largely from intentional investments in product innovation and integration of recent acquisitions such as PlastiFab, ThermoFoam, and Bonded Logic. New offerings like the ThermaFin Seven polyiso insulation and a temperature‑sensing adhesive gun illustrate Carlisle’s push to capture higher content per square foot and differentiate on performance. Although pricing is expected to be flat or modestly down in 2026, the firm’s focus on R&D—targeting 3% of sales—and a pipeline of ten new products aim to offset cost headwinds and drive incremental margin expansion, aligning with its Vision 2030 ambition.

Looking ahead, Carlisle projects low‑single‑digit revenue growth for 2026 with roughly 50 basis points of adjusted EBITDA margin improvement. The reaffirmation of Vision 2030 goals—$40 adjusted EPS, >25% ROIC, and EBITDA margins of at least 25% overall—signals confidence in its long‑term growth engine. While macroeconomic uncertainty tempers short‑term outlook, disciplined capital allocation, a strong cash position, and a clear acquisition strategy position Carlisle to capitalize on emerging opportunities in the North American building‑products market, making it a compelling play for investors seeking exposure to resilient, cash‑rich industrials.

Carlsmed Inc (CARL) Q4 2025 Earnings Call Transcript

Read Original Article
0

Comments

Want to join the conversation?

Loading comments...